PROGRESSIVE DECLINE OF HBSAG TITERS IN LONG-TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Iavarone, Massimo
Lampertico, Pietro
Vigano, Mauro
Facchetti, Floriana
Melotti, Silvia [1 ]
Lunghi, Giovanna [1 ]
Colombo, Massimo
机构：
[1] Univ Milan, Maggiore Hosp, Cent Lab, Milan, Italy
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
900
引用
收藏
页码：709A / 709A
页数：1
相关论文
共 50 条
  • [31] STOPPING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY BEFORE HBsAg LOSS IN HBeAg NEGATIVE CHB PATIENTS: FOLLOW-UP OF LONG TERM RESPONDERS
    Petersen, J.
    Buggisch, P.
    Hinrichsen, H.
    Berg, T.
    Wedemeyer, H.
    Cornberg, M.
    Stoehr, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S313 - S314
  • [32] Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy
    Tada, Toshifumi
    Kumada, Takashi
    Toyoda, Hidenori
    Kiriyama, Seiki
    Tanikawa, Makoto
    Hisanaga, Yasuhiro
    Kanamori, Akira
    Kitabtake, Shusuke
    Ito, Takanori
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 795 - 804
  • [33] HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B
    Chi, H.
    Arends, P.
    Wong, D. K.
    Yim, C.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S436 - S436
  • [34] Long-term prognosis of patients with hepatitis B infection: causes of death and utility of nucleos(t)ide analogue therapy
    Toshifumi Tada
    Takashi Kumada
    Hidenori Toyoda
    Seiki Kiriyama
    Makoto Tanikawa
    Yasuhiro Hisanaga
    Akira Kanamori
    Shusuke Kitabtake
    Takanori Ito
    Journal of Gastroenterology, 2015, 50 : 795 - 804
  • [35] Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B
    Li, Min-Ran
    Xi, Hong-Li
    Wang, Qin-Huan
    Hou, Feng-Qin
    Huo, Na
    Zhang, Xia-Xia
    Li, Fang
    Xu, Xiao-Yuan
    PLOS ONE, 2014, 9 (06):
  • [36] LONG TERM NUCLEOS(T)IDE ANALOGUE THERAPY REDUCED THE EXTENT OF HBV DNA INTEGRATION IN CHRONIC HEPATITIS B PATIENTS
    Chow, Ning
    Wong, Danny Ka-Ho
    Mak, Lung Yi
    Fung, James
    Seto, Wai Kay Walter
    Lai, Ching Lung
    Yuen, Man Fung
    HEPATOLOGY, 2020, 72 : 19A - 19A
  • [37] Nucleos(t)ide analogues therapy for chronic hepatitis B in Taiwan: Short-term versus long-term
    Peng C.-Y.
    Current Hepatitis Reports, 2013, 12 (3) : 181 - 187
  • [38] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES AND LONG-TERM VIROLOGICAL SUPPRESSION
    Fasano, M.
    Montrano, L.
    Ciarallo, M.
    Caccianotti, B.
    Giammario, A.
    Gioacchino, A.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S335 - S335
  • [39] Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
    Martin-Carbonero, Luz
    Teixeira, Tiago
    Poveda, Eva
    Plaza, Zulema
    Vispo, Eugenia
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    AIDS, 2011, 25 (01) : 73 - 79
  • [40] Nucleos(t)ide Analogue Discontinuation is not Associated with Increased Rates of HBsAg Loss in Chronic Hepatitis B
    Chi, Heng
    Hansen, Bettina E.
    Feld, Jordan J.
    Buti, Maria
    Brown, Ashley S.
    Carey, Ivana
    Fasano, Massimo
    Mutimer, David J.
    Deterding, Katja
    van Boemmel, Florian
    Yim, Colina
    de Knegt, Robert J.
    Santantonio, Teresa A.
    Welzel, Tania M.
    Pradat, Pierre
    Petersen, Joerg
    Wedemeyer, Heiner
    Berg, Thomas
    Zoulim, Fabien
    Wong, David K.
    Janssen, Harry L.
    HEPATOLOGY, 2016, 64 : 938A - 939A
12345